US2005196342A1PendingUtilityA1
Contrast agents
Priority: Jan 9, 1992Filed: Feb 10, 2005Published: Sep 8, 2005
Est. expiryJan 9, 2012(expired)· nominal 20-yr term from priority
A61K 49/1821A61K 49/1818A61K 49/223A61K 49/225
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Contrast agents comprising microbubble-generating carbohydrate microparticles having a surfactant admixed within the microparticulate structure, with the proviso that the surfactant is not a C 10-20 fatty acid, are disclosed. Processes for preparing contrast agents also are disclosed.
Claims
exact text as granted — not AI-modified1 - 13 . (canceled)
14 . The method of generating an enhanced echocardiographic image of a human or non-human body comprising: administering into the pulmonary system of said body an echocardiographic contrast enhancing amount of a contrast agent comprising gasmicrobubble-generating aggregates of microparticles; applying to a part of said body ultrasound at a frequency of 0.1 to 15 MHZ; and generating said image; said microparticles comprising a water soluble matrix material and a surfactant, the microbubbles generated by said aggregates comprising SF 6 or a fluorinated low molecular weight hydrocarbon, said aggregates being 20-125 Φm in size and said microparticles having an average size of 0.1 to 50 Φm.
15 . The method as claimed in claim 14 in which the surfactant is selected from the group consisting of straight chain aliphatic carboxylic acids and salts, sorbitan esters and mono- and di-glycerides thereof; aralkanoic acids and the salts thereof; steroid acids; sterols; straight chain aliphatic alcohols; phospholipids; alkali metal alkyl sulphates and sulphonated esters; polyoxyethylene-polyoxypropylene copolymers; polyoxyethylated sorbitan esters; and mixtures of any of the foregoing.
16 . The method as claimed in claim 14 in which the surfactant comprises a lipophilically modified carbohydrate.
17 . The method as claimed in claim 14 in which the surfactant is present in an amount of 0.1-2.0% w/w relative to the water soluble matrix.
18 . The method as claimed in claim 14 for which the microbubbles generated by said aggregates contain air in admixture with said SF 6 or fluorinated hydrocarbon.
19 . The method as claimed in claim 14 for which the microbubbles generated by said aggregates comprise carbon tetrafluoride.
20 . The method as claimed in claim 14 in which the water soluble matrix is a carbohydrate.
21 . The method as claimed in claim 20 in which the carbohydrate is a polysaccharide.
22 . The method as claimed in claim 20 in which the carbohydrate is a sugar alcohol.
23 . The method as claimed in claim 14 which is non-contrast giving before use, but which becomes effective on administration.
24 . The method as claimed in claim 15 which is non-contrast giving before use, but which becomes effective on administration.
25 . The method as claimed in claim 16 which is non-contrast giving before use, but which becomes effective on administration.
26 . The method as claimed in claim 17 which is non-contrast giving before use, but which becomes effective on administration.
27 . The method as claimed in claim 18 which is non-contrast giving before use, but which becomes effective on administration.
28 . The method as claimed in claim 19 which is non-contrast giving before use, but which becomes effective on administration.Join the waitlist — get patent alerts
Track US2005196342A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.